Thursday, April 30, 2020

Remdesivir Trials Suggest Potential Benefit in COVID-19; FDA Expected to Authorize the Drug (NEJM, Journal Watch, 2020-4-29)

https://www.jwatch.org/fw116595/2020/04/29/remdesivir-trials-suggest-potential-benefit-covid-19-fda?query=pfwTOC&jwd=000013567342&jspc=P